PERSPECTA

News from every angle

Back to headlines

Personalized mRNA Vaccine Shows Promise in Halting Cancer Recurrence

A breakthrough personalized mRNA vaccine has dramatically stopped cancer recurrence in clinical trials, offering new hope amid WHO warnings that global cancer cases could nearly double by 2050.

PostShare

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.